Company Filing History:
Years Active: 2013
Title: **Tyco M Scholtens - Innovator in Cancer Cell Imaging**
Introduction
Tyco M Scholtens is an accomplished inventor based in Enschede, Netherlands, recognized for his significant contribution to the field of cancer diagnostics. With a patent to his name, Scholtens has developed innovative methodologies that enhance the imaging of rare circulating tumor cells (CTCs), an important aspect of cancer research and treatment.
Latest Patents
One of Tyco M Scholtens' groundbreaking patents is titled "Imaging of immunomagnetically enriched rare cells." This invention provides a sophisticated method for removing excess unbound ferrofluid and effectively imaging immunomagnetically enriched circulating tumor cells. The patented system employs vessels designed with preformed grooves on the viewing surface, which optimally align and facilitate the imaging of cells. By utilizing centrifugation to separate unbound particles and applying an external force to transport the magnetically responsive particle-CTC complex toward a transparent collection wall, this invention allows for uniform distribution of particles and ease of imaging. The technology also serves a critical role in quantitative analysis and sample preparation, particularly when integrated with automated cell enumeration techniques for assessing CTCs in various diseases.
Career Highlights
Tyco M Scholtens currently works with Veridex, LLC, where his expertise and innovative approaches have contributed to advanced research and development in cancer diagnostics. His role in the company underscores his commitment to improving medical technologies and ensuring better patient outcomes through precision diagnostics.
Collaborations
In his professional journey, Scholtens has collaborated with notable colleagues, including Frederik Schreuder and Jan Greve. These partnerships have facilitated the exchange of ideas and innovations, further enhancing the impact of their collective research efforts in the field of oncology.
Conclusion
Tyco M Scholtens exemplifies the spirit of innovation with his contributions to cancer cell imaging technology. His patent not only advances the field of cancer research but also has the potential to improve diagnostic accuracy and patient care. As technology continues to evolve, the impact of Scholtens' work will undoubtedly play a crucial role in the ongoing fight against cancer.